GRNA Stock: GreenLight Biosciences Holdings Stock Price, Analysis & Insights
Get live GRNA stock price $0.30, comprehensive GreenLight Biosciences Holdings stock analysis, charts, news, and expert forecast. Real-time GRNA stock data and investment insights.
Loading chart data...
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
GreenLight Biosciences Holdings is a biotechnology firm focused on developing and commercializing ribonucleic acid (RNA) solutions. Its innovative products serve both the human health and agricultural industries. The company's human health portfolio ...
Company Information
- CEO
- Andrey Juan Zarur
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 280
Contact Information
- Address
- 200 Boston Avenue
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Higher growth potential with elevated volatility (Beta: 1.44)
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for GreenLight Biosciences Holdings shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for GreenLight Biosciences Holdings
- ⚠Investors should consider how GreenLight Biosciences Holdings fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
45.43M
P/E Ratio (TTM)
-0.27
Beta
1.44
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare GRNA with peer companies:
- Price
- $9.81
- Market cap
- 49.48M
- Price
- $4.97
- Market cap
- 48.67M
- Price
- $0.78
- Market cap
- 47.38M
- Price
- $0.11
- Market cap
- 12.04M
- Price
- $0.70
- Market cap
- 42.44M
- Price
- $1.00
- Market cap
- 40.85M
- Price
- $1.42
- Market cap
- 32.92M
- Price
- $0.92
- Market cap
- 25.72M
- Price
- $1.10
- Market cap
- 36.47M
- Price
- $75.15
- Market cap
- 4.54B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.